PMFA
VRTX icon

Plante Moran Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Plante Moran Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.5K Sell
169
-5
-3% -$2.33K ﹤0.01% 262
2025
Q4 		$78.9K Sell
174
-45
-21% -$19.4K 0.01% 264
2025
Q3 		$85.8K Hold
219
– – 0.01% 268
2025
Q2 		$97.5K Buy
219
+28
+15% +$12.9K 0.01% 240
2025
Q1 		$92.6K Hold
191
– – 0.01% 257
2024
Q4 		$76.9K Sell
191
-1
-0.5% -$464 0.01% 294
2024
Q3 		$89.3K Buy
192
+1
+0.5% +$480 0.01% 298
2024
Q2 		$89.5K Hold
191
– – 0.01% 260
2024
Q1 		$79.8K Hold
191
– – 0.01% 275
2023
Q4 		$77.7K Hold
191
– – 0.01% 272
2023
Q3 		$66.4K Hold
191
– – 0.01% 264
2023
Q2 		$67.2K Sell
191
-100
-34% -$33.7K 0.01% 264
2023
Q1 		$91.7K Hold
291
– – 0.01% 236
2022
Q4 		$84K Hold
291
– – 0.01% 248
2022
Q3 		$84K Sell
291
-20
-6% -$5.75K 0.01% 238
2022
Q2 		$88K Buy
311
+20
+7% +$5.35K 0.01% 233
2022
Q1 		$76K Sell
291
-50
-15% -$11.9K 0.01% 267
2021
Q4 		$75K Buy
341
+50
+17% +$9.72K 0.01% 292
2021
Q3 		$53K Buy
291
+141
+94% +$27.5K 0.01% 371
2021
Q2 		$30K Sell
150
-14
-9% -$2.93K 0.01% 477
2021
Q1 		$35K Buy
164
+50
+44% +$11K 0.01% 435
2020
Q4 		$27K Buy
114
+14
+14% +$3.21K 0.01% 464
2020
Q3 		$27K Sell
100
-3
-3% -$828 0.01% 434
2020
Q2 		$30K Sell
103
-20
-16% -$5.42K 0.01% 368
2020
Q1 		$29K Sell
123
-2
-2% -$459 0.01% 337
2019
Q4 		$27K Buy
125
+7
+6% +$1.42K 0.01% 416
2019
Q3 		$20K Buy
118
+10
+9% +$1.77K 0.01% 505
2019
Q2 		$20K Sell
108
-92
-46% -$16.1K 0.01% 481
2019
Q1 		$37K Buy
200
+100
+100% +$18.5K 0.01% 391
2018
Q4 		$17K Hold
100
– – 0.01% 447
2018
Q3 		$19K Hold
100
– – 0.01% 439
2018
Q2 		$17K Sell
100
-16
-14% -$2.48K 0.01% 495
2018
Q1 		$19K Buy
116
+16
+16% +$2.61K 0.01% 520
2017
Q4 		$15K Hold
100
– – 0.01% 541
2017
Q3 		$15K Hold
100
– – 0.01% 498
2017
Q2 		$13K Hold
100
– – 0.01% 528
2017
Q1 		$11K Sell
100
-48
-32% -$4.23K 0.01% 565
2016
Q4 		$11K Hold
148
– – 0.01% 579
2016
Q3 		$13K Sell
148
-27
-15% -$2.55K 0.01% 563
2016
Q2 		$15K Buy
175
+27
+18% +$2.33K 0.01% 473
2016
Q1 		$12K Sell
148
-177
-54% -$16K 0.01% 462
2015
Q4 		$41K Buy
325
+43
+15% +$5.19K 0.03% 315
2015
Q3 		$29K Buy
282
+122
+76% +$15.7K 0.02% 337
2015
Q2 		$20K Buy
160
+30
+23% +$3.78K 0.01% 418
2015
Q1 		$15K Buy
130
+30
+30% +$3.59K 0.01% 452
2014
Q4 		$12K Hold
100
– – 0.01% 504
2014
Q3 		$11K Sell
100
-21
-17% -$2K 0.01% 521
2014
Q2 		$11K Hold
121
– – 0.01% 516
2014
Q1 		$9K Hold
121
– – 0.01% 390
2013
Q4 		$9K Hold
121
– – 0.01% 476
2013
Q3 		$9K Buy
121
+21
+21% +$1.67K 0.01% 406
2013
Q2 		$8K Buy
+100
New +$7.36K 0.01% 385

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Plante Moran Financial Advisors's VRTX Position: Q1 2026 in Review

Plante Moran Financial Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q1 2026, selling an estimated $2.33K and leaving 169 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Plante Moran Financial Advisors first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $97.5K in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Plante Moran Financial Advisors held 169 shares of Vertex Pharmaceuticals worth $75.5K as of Q1 2026.
  • Plante Moran Financial Advisors sold 5 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.33K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q1 2026, its #262 holding.
  • Plante Moran Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Plante Moran Financial Advisors's Vertex Pharmaceuticals position peaked at $97.5K in Q2 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.